Description: Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, California.
Home Page: www.vivani.com
VANI Technical Analysis
1350 South Loop Road
Alameda,
CA
94502
United States
Phone:
415 506 8462
Officers
| Name | Title |
|---|---|
| Mr. Adam Mendelsohn Ph.D. | Co-Founder, CEO & Director |
| Mr. Truc Le M.B.A. | Chief Operations Officer |
| Dr. Lisa E. Porter M.D. | Chief Medical Officer |
| Mr. Donald Dwyer M.B.A. | Chief Business Officer & Corporate Secretary |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.2006 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2014-11-19 |
| Fiscal Year End: | December |
| Full Time Employees: | 36 |